Fig. 4From: Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALLRepresentative surveilled B-ALL cases negative for MRD conversion (NMRDC). Dynamic changes in tumor load were measured by both the LIGV assay and MCF. Arrows indicate discordant MRD values where there was detectable MRD by MCF but negative NGS-MRDBack to article page